Pharma Likelihood Of Approval
We are the trusted, gold standard intelligence provider to the world’s largest industries
GlobalData powers faster, more informed decisions with:
- Granular industry intelligence: We develop deep, vertical-specific intelligence tailored to your industry, providing 360° insight.​
- Exhaustive coverage: We synthesize our vast data universe into formats that support your decision-making needs, covering the sectors, themes, companies and geographies that matter to you. ​
- Proprietary datasets: We provide you with access to untapped pools of intelligence generated from our proprietary datasets and primary research capabilities. ​
- Robust methodologies: The quality and timeliness of our data is a key differentiator. We leverage robust research methodologies to turn millions of data points into trusted intelligence.
Thousands of companies, government organizations, and decision makers rely on GlobalData
We have a track record of serving truly diverse clients, including:
- Corporates: From helping the C-suite refine strategy to powering innovation in marketing and R&D, our corporate use cases are endless. ​
- Investment firms: We help financial analysts develop robust long-term strategies and get alpha signals before the rest. ​
- Professional services: We give consultants, legal, and accounting firms the critical insights to make faster, more informed decisions. ​
- Other sectors: From media to academia, we work with sectors as diverse as our data. ​
The trusted, actionable and future-proof insight you need to stay ahead
We have decades of experience in being the gold standard intelligence provider based on: ​
- Unique data: Proprietary datasets built from terabytes of data. Our unmatched intelligence gives you true strategic advantage.
- Expert analysis: Leverage collective expertise. Count on our extensive team of researchers, analysts, subject matter experts, and journalists, plus thousands of external thought-leaders.​
- Real intelligence over AI: Experience a level of analysis that leaves AI in the dust. Unlock the proprietary datasets unseen by AI and gain a decisive edge. ​
- Time-saving research solutions: Save hundreds of hours on research. Our comprehensive reports let you focus on delivering actionable insights - not searching for them. ​
- Unparalleled global coverage: Tap into insights from anywhere. Our extensive global coverage offers an unrivalled view of the market landscape.​
- One platform: Access all our unique data, expert analysis, and innovative solutions on one platform. ​
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Zatolmilast in Fragile X Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zatolmilast in Fragile X Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Zatolmilast in Fragile X SyndromeDrug Details:BPN-14770 is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Mitapivat Sulfate in Alpha Thalassaemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mitapivat Sulfate in Alpha Thalassaemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Mitapivat Sulfate in Alpha ThalassaemiaDrug Details:Mitapivat sulfate (Pyrukynd) act as anti anemic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - AUR-101 in Ankylosing Spondylitis (Bekhterev's Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AUR-101 in Ankylosing Spondylitis (Bekhterev's Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AUR-101 in Ankylosing Spondylitis (Bekhterev's Disease)Drug Details:AUR-101 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - AUR-101 in Psoriatic Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AUR-101 in Psoriatic Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AUR-101 in Psoriatic ArthritisDrug Details:AUR-101 is under development for the treatment of moderate-to-severe...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Resolvine ER in Vitreomacular Adhesion (VMA)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Resolvine ER in Vitreomacular Adhesion (VMA) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Resolvine ER in Vitreomacular Adhesion (VMA)Drug Details:Resolvine is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Larotrectinib Sulfate in Pediatric Diffuse Intrinsic Pontine Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Larotrectinib Sulfate in Pediatric Diffuse Intrinsic Pontine Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Larotrectinib Sulfate in Pediatric Diffuse Intrinsic Pontine GliomaDrug Details:Larotrectinib...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Entrectinib in Fibrosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Entrectinib in Fibrosarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Entrectinib in FibrosarcomaDrug Details:Entrectinib (Rozlytrek) belongs to phenylpiperazines class of compounds, acts as an...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Avalotcagene Ontaparvovec in Ornithine-Transcarbamylase Deficiency
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Avalotcagene Ontaparvovec in Ornithine-Transcarbamylase Deficiency report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Avalotcagene Ontaparvovec in Ornithine-Transcarbamylase DeficiencyDrug Details:DTX-301 is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - IONIS-FB-LRx in Geographic Atrophy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IONIS-FB-LRx in Geographic Atrophy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.IONIS-FB-LRx in Geographic AtrophyDrug Details:IONIS-FB-LRx is under development for the treatment of geographic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Cilostazol CR in Intermittent Claudication
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cilostazol CR in Intermittent Claudication report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cilostazol CR in Intermittent Claudication Drug Details: Cilostazol CR (PMR)...